Vertex Pharmaceuticals to acquire Crinetics Pharmaceuticals
Vertex Pharmaceuticals announced plans to acquire Crinetics Pharmaceuticals to bolster its pipeline and revenue projections. The deal is fully funded by committed bridge financing and is expected to contribute to significant growth and accretion by 2029.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day